Health workers in the Democratic Republic of Congo celebrated after the last patient left an Ebola treatment centre. The departure marks a major milestone in the response to the outbreak.
11:39 PMAl Jazeera18 stories from 7 sources
Ebola’s scale and containment milestones define a volatile health day
Day’s Recap
Supporting Articles
The Ebola outbreak in Congo has surpassed 10,000 cases and become the fastest-growing and most geographically extensive outbreak described in the article. Weak or inconsistent disease surveillance appears to have contributed to its spread across Africa.
11:50 AMFortune
Nigeria evacuated an Ebola patient more than a week after the country's first reported case. Investigators are still working to determine how the infection occurred and what risks it may pose.
2:16 PMThe New York Times
The U.S. government will stop taking enforcement action against compounding pharmacies that make six popular peptides, including wellness products such as BPC-157 and TB-500. The decision affects compounds that are not broadly approved as standard medicines.
4:07 PMMarketWatch
HHS is moving toward allowing the compounding of some unapproved peptides, amid political support from Robert F. Kennedy Jr. and the MAHA movement. Many of the wellness compounds involved have limited evidence of benefit.
12:35 PMStat News
Eli Lilly said its investigational drug retatrutide outperformed Novo Nordisk's Ozempic in reducing blood sugar and body weight in a large diabetes study. Retatrutide is a three-pathway drug that remains under development.
9:42 AMStat News
Eli Lilly says its triple-agonist diabetes drug delivered better results than Novo Nordisk’s Ozempic in a clinical study. The data reinforce expectations that the program could become a major source of Lilly’s future growth.
6:45 AMStat News
The investigation examines how Epic's dominance in electronic health records affects health care innovation and the adoption of AI tools. It focuses on the company's role as a gatekeeper between emerging technology companies and clinical workflows.
10:52 AMStat News
An investigation found that Epic selectively restricts access to patient data, putting competing software developers at a disadvantage and limiting the development of new health technology.
4:30 AMStat News11:39 PMAl Jazeera
Incredible celebrations as last patient leaves a DRC Ebola centre
Summary
Health workers in the Democratic Republic of Congo celebrated after the last patient left an Ebola treatment centre. The departure marks a major milestone in the response to the outbreak.
The centre reaching zero patients signals that the immediate treatment burden has fallen, but it
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The last discharge strengthens the outbreak response but leaves surveillance essential before officials can declare the threat over.
11:50 AMFortune
‘Every life saved is worth celebrating’: Congo suffers over 10,000 cases of the fastest-growing and farthest-reaching Ebola outbreak in history
Summary
The Ebola outbreak in Congo has surpassed 10,000 cases and become the fastest-growing and most geographically extensive outbreak described in the article. Weak or inconsistent disease surveillance appears to have contributed to its spread across Africa.
The decisive problem is not only transmission but the failure to detect and report cases
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The outbreak shows that weak surveillance can turn a containable Ebola flare-up into a regional public-health emergency.
2:16 PMThe New York Times
Nigeria’s Ebola Patient Evacuated as Investigators Press for Answers
Summary
Nigeria evacuated an Ebola patient more than a week after the country's first reported case. Investigators are still working to determine how the infection occurred and what risks it may pose.
The unresolved source of infection is the central operational problem because it limits authorities' ability
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Nigeria's response will test how quickly a high-risk pathogen can be detected, traced, and contained in Africa's most populous country.
4:07 PMMarketWatch
The U.S. government will no longer penalize American companies for making six popular peptides
Summary
The U.S. government will stop taking enforcement action against compounding pharmacies that make six popular peptides, including wellness products such as BPC-157 and TB-500. The decision affects compounds that are not broadly approved as standard medicines.
The policy reduces immediate regulatory risk for domestic compounders and may widen access to these
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A weaker enforcement posture could rapidly expand an unapproved peptide market before clinical evidence and oversight catch up.
12:35 PMStat News
STAT+: HHS moves to allow compounding of some unapproved peptides
Summary
HHS is moving toward allowing the compounding of some unapproved peptides, amid political support from Robert F. Kennedy Jr. and the MAHA movement. Many of the wellness compounds involved have limited evidence of benefit.
The proposed change would shift peptide access from a tightly constrained medical pathway toward broader
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The policy could normalize unapproved peptide use at scale while leaving patients to distinguish promising therapies from unsupported wellness claims.
9:42 AMStat News
STAT+: Lilly’s triple-G drug beats Ozempic in head-to-head study
Summary
Eli Lilly said its investigational drug retatrutide outperformed Novo Nordisk's Ozempic in reducing blood sugar and body weight in a large diabetes study. Retatrutide is a three-pathway drug that remains under development.
Lilly's result strengthens retatrutide's position in the next generation of obesity and diabetes medicines, where
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
If confirmed and approved, retatrutide could raise the efficacy benchmark and intensify competition in the fast-growing GLP-1 market.
6:45 AMStat News
STAT+: Lilly says ‘triple-G’ drug beat Novo’s Ozempic in diabetes study
Summary
Eli Lilly says its triple-agonist diabetes drug delivered better results than Novo Nordisk’s Ozempic in a clinical study. The data reinforce expectations that the program could become a major source of Lilly’s future growth.
The result strengthens Lilly’s position in the fast-growing metabolic-drug market and raises the competitive bar
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A credible efficacy edge could reshape the next phase of the diabetes-drug race and redirect billions in future sales.
10:52 AMStat News
STAT+: Why every health care AI company must face Epic
Summary
The investigation examines how Epic's dominance in electronic health records affects health care innovation and the adoption of AI tools. It focuses on the company's role as a gatekeeper between emerging technology companies and clinical workflows.
Epic's control over core clinical data and software gives it substantial influence over which AI
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Epic's platform position could determine which health care AI products scale and which remain outside clinical workflows.
4:30 AMStat News
STAT+: As Epic’s dominance grows, its iron grip is choking innovation in health technology
Summary
An investigation found that Epic selectively restricts access to patient data, putting competing software developers at a disadvantage and limiting the development of new health technology.
Epic’s control over hospitals and clinical data gives it power to shape which products can
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The concentration of health data and infrastructure in one vendor could turn interoperability into a competitive barrier.
Other Developments
A curated list of other prominent stories from this day.
Researchers identified a small group of brain cells that helps prevent dangerous blood pressure fluctuations even when average readings remain within a normal range. The finding points to a previously hidden cardiovascular risk and a potential target for treatment.
11:54 PMScienceDaily
A House lawmaker asked the Government Accountability Office to investigate whether the TrumpRx platform has actually saved Americans money on prescription drugs. The request challenges the evidence behind the platform's savings claims.
4:51 PMStat News
Reed Jobs argued that GLP-1 weight-loss drugs could help prevent some cancers by reducing obesity, a major risk factor for several malignancies. His claim concerns potential prevention through weight reduction, not evidence that these drugs treat cancer.
9:33 AMFortune
Researchers identified a protective mechanism in aging muscles that reduces strength while limiting cellular damage. In mice, restoring a key molecule improved muscle wasting and extended survival, pointing to a possible treatment target.
9:04 AMScienceDaily
A Finnish study found that 30 minutes of sauna exposure temporarily increased the number of white blood cells circulating in the bloodstream. The response resembles some of the immune changes associated with exercise and may help explain possible health benefits of sauna use.
8:37 AMScienceDaily
U.S. overdose deaths fell 27% in 2024 after years of increases, and preliminary data indicate another decline in 2025. The report examines the factors behind the reversal, particularly after the pandemic-era surge.
8:01 AMStat News
Sandoz says Europe’s medicines regulator is considering removing amoxicillin from the bloc’s critical-medicines list. The change could threaten the viability of the last European facility producing the antibiotic’s active ingredient from scratch.
5:34 AMBloomberg Markets
A pediatrician describes managing sharply divided parental responses to measles and the MMR vaccine, from urgent demand for vaccination to outright opposition.
4:30 AMStat News
A physician recounts freezing her eggs and argues that the process fell short of its promise of empowerment, exposing constraints and pressures embedded in the fertility industry.
4:30 AMStat News11:54 PMScienceDaily
Your blood pressure could be dangerous even when your numbers look normal
Summary
Researchers identified a small group of brain cells that helps prevent dangerous blood pressure fluctuations even when average readings remain within a normal range. The finding points to a previously hidden cardiovascular risk and a potential target for treatment.
The key shift is from treating blood pressure as a single average to recognizing instability
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Normal readings may not capture the blood pressure patterns that damage the heart and brain.
4:51 PMStat News
STAT+: Lawmaker wants government watchdog to probe TrumpRx over claims about drug savings
Summary
A House lawmaker asked the Government Accountability Office to investigate whether the TrumpRx platform has actually saved Americans money on prescription drugs. The request challenges the evidence behind the platform's savings claims.
The GAO review would subject TrumpRx's public claims to independent scrutiny and could compare advertised
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
An independent assessment could determine whether TrumpRx delivers measurable savings or mainly functions as a promotional vehicle.
9:33 AMFortune
Steve Jobs’ son says the GLP-1 revolution could help fight cancer: ‘Some of the most important drugs we’ve ever actually seen come to market’
Summary
Reed Jobs argued that GLP-1 weight-loss drugs could help prevent some cancers by reducing obesity, a major risk factor for several malignancies. His claim concerns potential prevention through weight reduction, not evidence that these drugs treat cancer.
The strongest case is indirect: sustained weight loss may lower obesity-related cancer risk, but that
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
GLP-1 drugs could eventually influence cancer prevention, but that possibility remains a hypothesis rather than a demonstrated oncology benefit.
9:04 AMScienceDaily
Scientists discover a hidden reason why muscles weaken with age
Summary
Researchers identified a protective mechanism in aging muscles that reduces strength while limiting cellular damage. In mice, restoring a key molecule improved muscle wasting and extended survival, pointing to a possible treatment target.
The study reframes some age-related weakness as a tradeoff: muscle cells may sacrifice performance to
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A mechanism that links muscle loss to cellular protection could open a new drug strategy for sarcopenia, if it translates beyond mice.
8:37 AMScienceDaily
A single sauna session sends immune cells surging through your body
Summary
A Finnish study found that 30 minutes of sauna exposure temporarily increased the number of white blood cells circulating in the bloodstream. The response resembles some of the immune changes associated with exercise and may help explain possible health benefits of sauna use.
The key finding is a short-term change in immune-cell circulation, not proof that sauna bathing
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Sauna use may affect immune physiology, but the study does not yet justify treating it as an immune-boosting intervention.
8:01 AMStat News
What has actually caused the decline in drug overdose deaths?
Summary
U.S. overdose deaths fell 27% in 2024 after years of increases, and preliminary data indicate another decline in 2025. The report examines the factors behind the reversal, particularly after the pandemic-era surge.
The decline is real, but no single explanation can account for it; wider access to
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The reversal offers evidence that overdose policy and treatment can reduce mortality, while leaving unanswered whether the gains will last.
5:34 AMBloomberg Markets
Sandoz Warns EU May Scrap Antibiotic Protection, Harm Plant
Summary
Sandoz says Europe’s medicines regulator is considering removing amoxicillin from the bloc’s critical-medicines list. The change could threaten the viability of the last European facility producing the antibiotic’s active ingredient from scratch.
Removing amoxicillin from the protected list would weaken the policy support for domestic production and
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A regulatory decision aimed at streamlining medicine classifications could instead erode Europe’s remaining antibiotic manufacturing capacity.
4:30 AMStat News
Opinion: How pediatricians like me are helping families stay calm and informed about measles
Summary
A pediatrician describes managing sharply divided parental responses to measles and the MMR vaccine, from urgent demand for vaccination to outright opposition.
The measles response now forces pediatricians to navigate both vaccine access and vaccine refusal in
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Clinicians are becoming a frontline defense against measles misinformation as vaccine confidence fragments.
4:30 AMStat News
Opinion: Freezing my eggs showed me just how anti-feminist the fertility industry can be
Summary
A physician recounts freezing her eggs and argues that the process fell short of its promise of empowerment, exposing constraints and pressures embedded in the fertility industry.
Egg freezing can expand reproductive options while shifting responsibility for structural barriers onto individual women.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The experience challenges the idea that fertility preservation alone delivers reproductive freedom.
Make it yours
Build Your First Pass.
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!